Awarded

PR22-012 - An instrument for biopharmaceutical cell line development

Descriptions

NIBRT is looking to acquire an instrument for cell line development. The ideal solution will be one that allows for multiplexed and automated investigation of thousands of individual clones per experiment to find the best producing cells for recombinant protein production. The ideal solution will have advanced high-resolution imaging capabilities to ensure monoclonality of generated cell lines and will enable the recovery of clonal populations for further processing, expansion, and banking. The ideal solution will also facilitate on board assays for the determination of expressed product titre or other potential quality attributes to facilitate identification of the best potential clones for further investigation in an automated and simplified manner.

Timeline

Published Date :

19th Oct 2022 2 years ago

Deadline :

27th Jun 2022 2 years ago

Tender Awarded :

1 Supplier

Awarded date :

N/A

Contract Start :

N/A

Contract End :

N/A

Tender Regions

Tender Lot Details

1 Tender Lot

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Awarded

Assign to :

Tender Progress :

0%

Details

Notice Type :

Open opportunity

Tender Identifier :

IT-378-246-T: 2024 - 001

TenderBase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Region :

North Region

Attachments :

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Designation :

Chief Executive Officer

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors